| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 20 | 2022 | 669 | 1.500 |
Why?
|
| Glucose | 20 | 2025 | 842 | 1.060 |
Why?
|
| Adipocytes, Brown | 2 | 2021 | 28 | 0.830 |
Why?
|
| Liver | 17 | 2023 | 1764 | 0.640 |
Why?
|
| Obesity | 16 | 2022 | 2329 | 0.590 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 361 | 0.560 |
Why?
|
| Adipose Tissue, White | 10 | 2025 | 88 | 0.550 |
Why?
|
| Vibrio cholerae | 11 | 1999 | 28 | 0.540 |
Why?
|
| Mice | 50 | 2025 | 17574 | 0.530 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2015 | 139 | 0.510 |
Why?
|
| MicroRNAs | 2 | 2020 | 871 | 0.500 |
Why?
|
| Adipose Tissue | 6 | 2020 | 475 | 0.480 |
Why?
|
| Hyperglycemia | 6 | 2021 | 225 | 0.470 |
Why?
|
| Gene Expression Regulation | 13 | 2023 | 2318 | 0.440 |
Why?
|
| Hypoglycemic Agents | 4 | 2022 | 457 | 0.440 |
Why?
|
| Animals | 56 | 2025 | 33114 | 0.420 |
Why?
|
| Mice, Knockout | 22 | 2025 | 3704 | 0.400 |
Why?
|
| Blood Glucose | 7 | 2021 | 1086 | 0.400 |
Why?
|
| Fatty Acids | 5 | 2023 | 352 | 0.390 |
Why?
|
| Diet, High-Fat | 8 | 2022 | 238 | 0.380 |
Why?
|
| STAT1 Transcription Factor | 3 | 2020 | 69 | 0.360 |
Why?
|
| Adipocytes, White | 3 | 2021 | 26 | 0.360 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 393 | 0.350 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 6 | 2017 | 320 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 21 | 2025 | 4488 | 0.340 |
Why?
|
| Oleanolic Acid | 1 | 2010 | 7 | 0.340 |
Why?
|
| Insulin | 10 | 2022 | 1132 | 0.330 |
Why?
|
| Adipocytes | 3 | 2025 | 167 | 0.310 |
Why?
|
| Peptide Hormones | 3 | 2017 | 70 | 0.310 |
Why?
|
| Fasting | 5 | 2023 | 300 | 0.290 |
Why?
|
| Perilipin-2 | 3 | 2017 | 10 | 0.290 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 460 | 0.290 |
Why?
|
| Signal Transduction | 9 | 2021 | 4471 | 0.280 |
Why?
|
| Body Temperature | 2 | 2025 | 120 | 0.270 |
Why?
|
| Cells, Cultured | 10 | 2021 | 2898 | 0.270 |
Why?
|
| Gene Deletion | 4 | 2021 | 768 | 0.270 |
Why?
|
| Energy Metabolism | 9 | 2021 | 762 | 0.250 |
Why?
|
| Insulin-Secreting Cells | 3 | 2021 | 132 | 0.250 |
Why?
|
| Body Temperature Regulation | 2 | 2025 | 50 | 0.240 |
Why?
|
| Adipose Tissue, Brown | 5 | 2021 | 84 | 0.240 |
Why?
|
| Marriage | 1 | 2025 | 27 | 0.230 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2025 | 9 | 0.230 |
Why?
|
| Hydatidiform Mole | 1 | 2025 | 19 | 0.230 |
Why?
|
| Contraception Behavior | 1 | 2025 | 29 | 0.230 |
Why?
|
| Phosphoproteins | 2 | 2004 | 420 | 0.230 |
Why?
|
| Aspartic Acid | 1 | 2025 | 81 | 0.230 |
Why?
|
| Microfilament Proteins | 2 | 2017 | 264 | 0.230 |
Why?
|
| Postprandial Period | 1 | 2025 | 88 | 0.230 |
Why?
|
| Lipolysis | 2 | 2004 | 73 | 0.230 |
Why?
|
| Homeostasis | 7 | 2021 | 686 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2022 | 1353 | 0.220 |
Why?
|
| Inflammation | 3 | 2020 | 1417 | 0.220 |
Why?
|
| Diet | 2 | 2010 | 1101 | 0.210 |
Why?
|
| Hyperinsulinism | 2 | 2021 | 62 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2025 | 103 | 0.210 |
Why?
|
| Thermogenesis | 3 | 2021 | 50 | 0.210 |
Why?
|
| Cytotoxins | 3 | 1999 | 23 | 0.210 |
Why?
|
| Muscle, Skeletal | 3 | 2010 | 979 | 0.200 |
Why?
|
| Carrier Proteins | 5 | 2021 | 1012 | 0.200 |
Why?
|
| Peptide Fragments | 2 | 2017 | 745 | 0.200 |
Why?
|
| Leptin | 5 | 2021 | 218 | 0.200 |
Why?
|
| Fatty Liver | 3 | 2010 | 204 | 0.190 |
Why?
|
| Insulins | 1 | 2022 | 19 | 0.190 |
Why?
|
| Alcohol Drinking | 1 | 2025 | 337 | 0.190 |
Why?
|
| Diabetic Nephropathies | 1 | 2023 | 113 | 0.190 |
Why?
|
| PPAR alpha | 2 | 2023 | 53 | 0.190 |
Why?
|
| Hepatocytes | 8 | 2017 | 232 | 0.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2022 | 51 | 0.180 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2021 | 24 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 20 | 0.180 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2021 | 31 | 0.180 |
Why?
|
| PPAR gamma | 2 | 2020 | 86 | 0.180 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 28 | 0.180 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 13 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2025 | 576 | 0.180 |
Why?
|
| Osteocalcin | 1 | 2021 | 45 | 0.180 |
Why?
|
| Cholera | 6 | 1999 | 34 | 0.180 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2021 | 24 | 0.180 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2021 | 32 | 0.180 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2021 | 17 | 0.170 |
Why?
|
| India | 9 | 2025 | 228 | 0.170 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 108 | 0.170 |
Why?
|
| Lipodystrophy | 1 | 2021 | 32 | 0.170 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2021 | 31 | 0.170 |
Why?
|
| CD11c Antigen | 1 | 2020 | 40 | 0.170 |
Why?
|
| Organelle Biogenesis | 1 | 2020 | 19 | 0.170 |
Why?
|
| Neurons | 3 | 2021 | 1919 | 0.170 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2020 | 36 | 0.160 |
Why?
|
| Hypothalamus | 2 | 2021 | 194 | 0.160 |
Why?
|
| Oligopeptides | 1 | 2020 | 115 | 0.160 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 4406 | 0.160 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 23 | 0.160 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 33 | 0.160 |
Why?
|
| Glucose Tolerance Test | 4 | 2021 | 199 | 0.160 |
Why?
|
| Autophagy | 3 | 2017 | 403 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2017 | 122 | 0.160 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 21 | 0.150 |
Why?
|
| Patched-1 Receptor | 1 | 2019 | 38 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2011 | 169 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 286 | 0.150 |
Why?
|
| Pituitary Gland | 1 | 2019 | 77 | 0.150 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2011 | 144 | 0.150 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 37 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2025 | 1229 | 0.150 |
Why?
|
| Mice, Obese | 6 | 2022 | 73 | 0.140 |
Why?
|
| Integrases | 1 | 2019 | 153 | 0.140 |
Why?
|
| Subcutaneous Fat | 1 | 2018 | 34 | 0.140 |
Why?
|
| Adipogenesis | 2 | 2009 | 79 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2021 | 503 | 0.140 |
Why?
|
| Fibroma | 1 | 2018 | 29 | 0.140 |
Why?
|
| Ossification, Heterotopic | 1 | 2018 | 37 | 0.140 |
Why?
|
| Liver X Receptors | 1 | 2017 | 14 | 0.140 |
Why?
|
| Oxidation-Reduction | 5 | 2023 | 425 | 0.140 |
Why?
|
| Gene Products, vpr | 1 | 2017 | 16 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2017 | 6 | 0.140 |
Why?
|
| Adaptation, Physiological | 2 | 2013 | 259 | 0.140 |
Why?
|
| Appetite Regulation | 1 | 2017 | 44 | 0.130 |
Why?
|
| Mitochondria | 2 | 2021 | 731 | 0.130 |
Why?
|
| Metaplasia | 1 | 2018 | 213 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 62 | 0.130 |
Why?
|
| Metabolomics | 1 | 2020 | 456 | 0.130 |
Why?
|
| Triglycerides | 4 | 2017 | 597 | 0.130 |
Why?
|
| Male | 27 | 2025 | 62050 | 0.130 |
Why?
|
| Humans | 37 | 2025 | 126020 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2012 | 674 | 0.120 |
Why?
|
| Eating | 2 | 2015 | 359 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 25 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 402 | 0.120 |
Why?
|
| Proinsulin | 1 | 2015 | 13 | 0.120 |
Why?
|
| Female | 22 | 2025 | 67877 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 1996 | 171 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 866 | 0.120 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 2311 | 0.120 |
Why?
|
| Hypogonadism | 1 | 2019 | 319 | 0.110 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2017 | 113 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2015 | 106 | 0.110 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2015 | 80 | 0.110 |
Why?
|
| Lipodystrophy, Congenital Generalized | 1 | 2014 | 5 | 0.110 |
Why?
|
| Gluconeogenesis | 3 | 2010 | 93 | 0.110 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2014 | 32 | 0.110 |
Why?
|
| Circadian Rhythm | 2 | 2016 | 305 | 0.110 |
Why?
|
| Transcription Factors | 4 | 2023 | 2344 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 130 | 0.110 |
Why?
|
| HIV-1 | 1 | 2017 | 468 | 0.110 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2015 | 119 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 443 | 0.100 |
Why?
|
| Adipokines | 3 | 2021 | 111 | 0.100 |
Why?
|
| Lipids | 3 | 2007 | 550 | 0.100 |
Why?
|
| ARNTL Transcription Factors | 1 | 2013 | 44 | 0.100 |
Why?
|
| Estrogens | 1 | 2015 | 424 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 363 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2015 | 419 | 0.090 |
Why?
|
| Dietary Fats | 2 | 2011 | 271 | 0.090 |
Why?
|
| Peptidomimetics | 1 | 2011 | 12 | 0.090 |
Why?
|
| Receptors, Ghrelin | 1 | 2011 | 29 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2021 | 299 | 0.090 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2012 | 107 | 0.090 |
Why?
|
| HeLa Cells | 7 | 2006 | 688 | 0.090 |
Why?
|
| Macrophages | 1 | 2015 | 633 | 0.090 |
Why?
|
| Lipid Metabolism | 4 | 2017 | 356 | 0.080 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2010 | 17 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 987 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2015 | 682 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1398 | 0.080 |
Why?
|
| Glucose-6-Phosphate | 1 | 2010 | 4 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2020 | 1014 | 0.080 |
Why?
|
| Cytokines | 1 | 1996 | 1312 | 0.080 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2010 | 160 | 0.080 |
Why?
|
| Lipoproteins, VLDL | 1 | 2010 | 53 | 0.080 |
Why?
|
| RNA Interference | 3 | 2020 | 495 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2011 | 1540 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 189 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 582 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2010 | 177 | 0.080 |
Why?
|
| Kidney | 5 | 2023 | 1279 | 0.080 |
Why?
|
| Cholera Toxin | 3 | 1999 | 43 | 0.070 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2008 | 17 | 0.070 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 10 | 0.070 |
Why?
|
| Aging | 2 | 2017 | 1190 | 0.070 |
Why?
|
| Disease Outbreaks | 4 | 1999 | 307 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 772 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2013 | 756 | 0.070 |
Why?
|
| COUP Transcription Factor II | 1 | 2009 | 96 | 0.070 |
Why?
|
| Proteins | 2 | 2025 | 1018 | 0.070 |
Why?
|
| Weight Loss | 1 | 2011 | 503 | 0.070 |
Why?
|
| Perilipin-1 | 2 | 2004 | 7 | 0.070 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2008 | 156 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2010 | 826 | 0.070 |
Why?
|
| Uncoupling Protein 1 | 2 | 2021 | 31 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2008 | 78 | 0.070 |
Why?
|
| Fibrillin-1 | 2 | 2017 | 54 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1003 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2023 | 192 | 0.060 |
Why?
|
| Protein Binding | 2 | 2021 | 1670 | 0.060 |
Why?
|
| Ovary | 2 | 2019 | 358 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 578 | 0.060 |
Why?
|
| Adult | 7 | 2025 | 30235 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 231 | 0.060 |
Why?
|
| HIV Infections | 1 | 2017 | 1948 | 0.060 |
Why?
|
| Cholesterol | 1 | 2008 | 538 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 371 | 0.060 |
Why?
|
| Ion Channels | 3 | 2013 | 200 | 0.060 |
Why?
|
| Genes, Reporter | 2 | 2021 | 343 | 0.060 |
Why?
|
| Mitochondrial Proteins | 3 | 2013 | 272 | 0.060 |
Why?
|
| Young Adult | 3 | 2025 | 9615 | 0.060 |
Why?
|
| Apoptosis | 2 | 2017 | 1805 | 0.050 |
Why?
|
| Health Surveys | 1 | 2025 | 247 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2004 | 98 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 1210 | 0.050 |
Why?
|
| Intestinal Mucosa | 2 | 1999 | 755 | 0.050 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 9 | 0.050 |
Why?
|
| Flavoproteins | 1 | 2023 | 20 | 0.050 |
Why?
|
| Biological Transport | 2 | 2018 | 325 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 2553 | 0.050 |
Why?
|
| Auranofin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Sugars | 1 | 2022 | 18 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1569 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2025 | 402 | 0.050 |
Why?
|
| Islets of Langerhans | 2 | 2017 | 146 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 1889 | 0.050 |
Why?
|
| Hydroxylation | 1 | 2021 | 50 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 90 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 74 | 0.040 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2021 | 35 | 0.040 |
Why?
|
| Carnitine | 1 | 2021 | 68 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 100 | 0.040 |
Why?
|
| Pregnancy | 2 | 2025 | 7404 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 92 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 41 | 0.040 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2002 | 135 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 20 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 284 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2020 | 49 | 0.040 |
Why?
|
| Virulence | 2 | 1999 | 263 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 160 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 828 | 0.040 |
Why?
|
| Uncoupling Protein 2 | 2 | 2013 | 13 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 83 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 376 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2002 | 263 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3649 | 0.040 |
Why?
|
| Mutation | 3 | 2025 | 5928 | 0.040 |
Why?
|
| Shigella flexneri | 1 | 1999 | 16 | 0.040 |
Why?
|
| Calcium | 2 | 2022 | 1029 | 0.040 |
Why?
|
| Salmonella Infections | 1 | 1999 | 31 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 18 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 52 | 0.040 |
Why?
|
| Middle Aged | 5 | 2025 | 27300 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2019 | 45 | 0.040 |
Why?
|
| CHO Cells | 2 | 1996 | 149 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 3603 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 291 | 0.040 |
Why?
|
| Ghrelin | 2 | 2011 | 57 | 0.040 |
Why?
|
| Cricetinae | 2 | 1996 | 365 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 60 | 0.040 |
Why?
|
| Cell Line | 2 | 2017 | 2562 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 475 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 445 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 1999 | 167 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2020 | 758 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 58 | 0.040 |
Why?
|
| Ileum | 1 | 1999 | 123 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 509 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2020 | 518 | 0.040 |
Why?
|
| Body Composition | 1 | 2021 | 541 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1225 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 1998 | 987 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2015 | 709 | 0.030 |
Why?
|
| Appetite Depressants | 1 | 2017 | 23 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 191 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2008 | 93 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2017 | 97 | 0.030 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2018 | 90 | 0.030 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Reproduction | 1 | 2019 | 218 | 0.030 |
Why?
|
| Glutamine | 1 | 2018 | 196 | 0.030 |
Why?
|
| Sterol Esterase | 1 | 2017 | 19 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2010 | 2547 | 0.030 |
Why?
|
| Tunicamycin | 1 | 2017 | 8 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Oleic Acid | 1 | 2017 | 15 | 0.030 |
Why?
|
| Testis | 1 | 2019 | 406 | 0.030 |
Why?
|
| Metabolome | 1 | 2020 | 316 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 1763 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 414 | 0.030 |
Why?
|
| Enterobacteriaceae | 1 | 1997 | 41 | 0.030 |
Why?
|
| Immunodiffusion | 1 | 1996 | 22 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2021 | 609 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 1996 | 33 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 414 | 0.030 |
Why?
|
| Progeria | 1 | 2016 | 16 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 298 | 0.030 |
Why?
|
| Adolescent | 4 | 2025 | 19936 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1996 | 292 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 223 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 158 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 947 | 0.030 |
Why?
|
| Body Weight | 2 | 2012 | 968 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 533 | 0.030 |
Why?
|
| Phenols | 1 | 2015 | 64 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 781 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 1206 | 0.030 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2014 | 4 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 351 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 656 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 588 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 189 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6085 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 183 | 0.030 |
Why?
|
| Dependovirus | 1 | 2015 | 144 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 253 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 600 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 913 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2015 | 327 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 638 | 0.020 |
Why?
|
| Cercopithecidae | 1 | 2011 | 8 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 3388 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 146 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1379 | 0.020 |
Why?
|
| Phenotype | 3 | 2008 | 4306 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3483 | 0.020 |
Why?
|
| Diarrhea | 1 | 1993 | 305 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 195 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 129 | 0.020 |
Why?
|
| Models, Biological | 2 | 2006 | 1372 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1937 | 0.020 |
Why?
|
| Anthropometry | 1 | 2011 | 191 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 2011 | 29 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2011 | 31 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 91 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 320 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 264 | 0.020 |
Why?
|
| Perilipin-3 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Phosphofructokinase-1 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 187 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 228 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 170 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 495 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2010 | 43 | 0.020 |
Why?
|
| Phosphofructokinase-2 | 1 | 2010 | 22 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 205 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 2012 | 315 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2009 | 25 | 0.020 |
Why?
|
| Glycolysis | 1 | 2010 | 167 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2009 | 63 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 643 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2008 | 17 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2009 | 53 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2008 | 22 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 75 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2011 | 243 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 284 | 0.020 |
Why?
|
| Response Elements | 1 | 2008 | 99 | 0.020 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2008 | 59 | 0.020 |
Why?
|
| Methylation | 1 | 2008 | 197 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1593 | 0.020 |
Why?
|
| Rabbits | 2 | 1999 | 610 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2009 | 200 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 235 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 6006 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 2008 | 99 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1486 | 0.020 |
Why?
|
| Culture Media | 2 | 1999 | 170 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 2 | 1999 | 99 | 0.020 |
Why?
|
| Birth Weight | 1 | 2008 | 340 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 537 | 0.020 |
Why?
|
| Heterozygote | 1 | 2009 | 690 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 20 | 0.020 |
Why?
|
| Cholic Acid | 1 | 2006 | 19 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2006 | 42 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 965 | 0.020 |
Why?
|
| Muscles | 1 | 2006 | 224 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 379 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2005 | 43 | 0.010 |
Why?
|
| Prevalence | 2 | 2008 | 2577 | 0.010 |
Why?
|
| Pancreas | 1 | 2006 | 215 | 0.010 |
Why?
|
| Peptide Library | 1 | 2004 | 57 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 648 | 0.010 |
Why?
|
| RNA | 1 | 2007 | 523 | 0.010 |
Why?
|
| Electron Transport | 1 | 2003 | 60 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 2003 | 42 | 0.010 |
Why?
|
| Immunogenetics | 1 | 2002 | 9 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 2002 | 19 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 2002 | 69 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2002 | 108 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2005 | 714 | 0.010 |
Why?
|
| Adiponectin | 1 | 2002 | 124 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1850 | 0.010 |
Why?
|
| Risk Factors | 2 | 2008 | 10386 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 525 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 1002 | 0.010 |
Why?
|
| Phospholipases | 1 | 1999 | 9 | 0.010 |
Why?
|
| Acetophenones | 1 | 1999 | 11 | 0.010 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2002 | 229 | 0.010 |
Why?
|
| Hemolysin Proteins | 1 | 1999 | 24 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3679 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1999 | 157 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 762 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 1999 | 101 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 1348 | 0.010 |
Why?
|
| Tight Junctions | 1 | 1999 | 35 | 0.010 |
Why?
|
| Body Water | 1 | 1999 | 87 | 0.010 |
Why?
|
| Caseins | 1 | 1998 | 58 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1999 | 82 | 0.010 |
Why?
|
| Myocardium | 1 | 2003 | 839 | 0.010 |
Why?
|
| Hemolysis | 1 | 1999 | 102 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1998 | 196 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1998 | 109 | 0.010 |
Why?
|
| Genome, Bacterial | 1 | 1999 | 209 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 1611 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1999 | 294 | 0.010 |
Why?
|
| Actins | 1 | 1999 | 311 | 0.010 |
Why?
|
| Child | 2 | 2015 | 25061 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 819 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 565 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 763 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 282 | 0.010 |
Why?
|
| Intestines | 1 | 1999 | 579 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1993 | 64 | 0.010 |
Why?
|
| Bangladesh | 1 | 1993 | 40 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 5049 | 0.010 |
Why?
|
| Electrolytes | 1 | 1993 | 57 | 0.010 |
Why?
|
| Hematocrit | 1 | 1993 | 108 | 0.010 |
Why?
|
| Genotype | 1 | 1999 | 2601 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3256 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 6543 | 0.010 |
Why?
|
| Aged | 2 | 2002 | 19973 | 0.010 |
Why?
|
| Acute Disease | 1 | 1993 | 1046 | 0.010 |
Why?
|
| Feces | 1 | 1993 | 702 | 0.000 |
Why?
|
| Infant | 1 | 1993 | 12762 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1993 | 14330 | 0.000 |
Why?
|